Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia
about
Immunotherapy for tularemiaLive attenuated tularemia vaccines: recent developments and future goals.Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response.Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.Use of a capture-based pathogen transcript enrichment strategy for RNA-Seq analysis of the Francisella tularensis LVS transcriptome during infection of murine macrophages.Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella speciesB1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.MyD88-dependent signaling prolongs survival and reduces bacterial burden during pulmonary infection with virulent Francisella tularensis.Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α.A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.Uncovering the components of the Francisella tularensis virulence stealth strategyInclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent Francisella tularensisHematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.Editorial: Leukocytes in tularemia--so many cells, so little time.Comparison of gene expression in post-smolt Atlantic salmon challenged by LF-89-like and EM-90-like Piscirickettsia salmonis isolates reveals differences in the immune response associated with pathogenicity.Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.
P2860
Q26864945-AAC26EBB-D4F5-4C42-8829-CBFA8E5EBD42Q30222801-F9550580-C953-4237-8D32-68A26AF420C4Q30409782-DE719DC9-0882-4D73-8434-583C500A3813Q34291236-86421364-896D-4252-8C7F-85BD47D61E83Q34308451-8AE493F6-6C32-47FB-B5F3-DC99F9E4792FQ34784967-7D0F6AE4-7027-4332-BE38-D7947E16AF7DQ35025533-7EA6E601-FE5E-4A1E-9A83-DA51F2513535Q35064098-6732F239-54DD-4E3D-9D86-8C5144E67258Q36675682-A5C186AE-0D1B-4C00-9CA0-09EAFB42FD97Q37059554-8A9C621F-4679-45A8-B56A-3162112C4B56Q37123766-DB72456B-8FA9-4304-ADD5-9CC9032E3D34Q37218211-9C1B7E73-65F7-435B-A986-38D1F53CDCC9Q37252363-E138D99D-B61C-4A45-8222-ECB2A212DABDQ37428644-416D41B0-A149-4BF5-8190-EB30B9D0996BQ38196816-DDA1C4D1-40B0-49AD-B598-665CD70076B4Q39471468-7A8AAF46-18F8-4120-B8CF-DF1CE03447ACQ41993864-4B3F5834-F9AA-4772-99E4-DE30C2D6DFADQ43192563-CCF8CDDE-396A-4123-BDEA-3AD1592E7715Q47809204-0AA600BD-FB3C-4309-BC38-81FCC937B151Q52571082-76C2C60F-9697-4779-A6A6-292417505FAF
P2860
Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Generation of a convalescent m ...... ents for survival of tularemia
@ast
Generation of a convalescent m ...... ents for survival of tularemia
@en
Generation of a convalescent m ...... ents for survival of tularemia
@nl
type
label
Generation of a convalescent m ...... ents for survival of tularemia
@ast
Generation of a convalescent m ...... ents for survival of tularemia
@en
Generation of a convalescent m ...... ents for survival of tularemia
@nl
prefLabel
Generation of a convalescent m ...... ents for survival of tularemia
@ast
Generation of a convalescent m ...... ents for survival of tularemia
@en
Generation of a convalescent m ...... ents for survival of tularemia
@nl
P2093
P2860
P1433
P1476
Generation of a convalescent m ...... ents for survival of tularemia
@en
P2093
Catharine M Bosio
Dana P Scott
Deborah D Crane
P2860
P304
P356
10.1371/JOURNAL.PONE.0033349
P407
P577
2012-03-12T00:00:00Z